Bruker Corporation (BRKR) has made a series of acquisitions in 2023, boosting its sales and growth prospects. The company is now guiding for $3.26 billion in sales in 2024, with organic growth expected to contribute 6%. Adjusted earnings are projected to increase to $2.71-$2.76 per share. These acquisitions have increased Bruker’s leverage ratios to about 3 times, but management believes that the growth opportunities justify the higher debt levels.